Method
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.85% · OPTIONAL
· Orthopedic, Prosthetic & Surgical Appliances & Supplies
RESEARCH SNAPSHOTInogen Inc's latest supported as-filed period reports revenue of $83.5M, 5.5% above the comparable as-filed period; gross margin moved 41 basis points lower on the same comparison basis. Every value below links to its SEC accession and metric lineage.
No material rule-based research observation currently meets GrossPattern's Insight value threshold. Current state, direction, and filing evidence remain available below.
A multidimensional view of the latest comparable filing—not a composite score or recommendation.
Level · gp.fundamentals.capex_revenue_ratio
Raw value 0.85% · OPTIONAL
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
Raw value 3.53% · OPTIONAL
Yoy · gp.fundamentals.revenue
Raw value 5.50% · CORE
Level · gp.fundamentals.inventory_revenue_ratio
Raw value 34.28% · OPTIONAL
Level · gp.fundamentals.gross_margin
Raw value 51.81% · CORE
Level · gp.fundamentals.operating_margin
Raw value -6.10% · CORE
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
Business direction, financial quality, capital allocation, and governance evidence remain separate—never collapsed into a recommendation score.
Interpretation boundary Direction describes measurable company fundamentals. Governance reports observable evidence only; it does not grade management character or predict stock returns.
Latest available comparable states within 180 days, normalized with robust median/MAD statistics.
The most important deterministic changes, ranked by magnitude, issuer history, persistence, and accounting profile.
This cluster groups 2 independently calculated changes: Inventory increased 17.8%; Inventory / revenue moved 357 bp higher.
2 evidence-backed componentsThis cluster groups 3 independently calculated changes: Revenue increased 5.5%; Operating margin moved 164 bp higher; Operating income increased 16.9%.
3 evidence-backed componentsInventory changed +17.8% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Each point keeps the date investors could first observe it and its accession.
INGN · as filed with the SEC · reported-date aware
Direct SEC links, filing dates, report periods, and amendment flags.
0002079955-26-000003SEC ↗4Sep 3, 2026Period Sep 1, 20260002031211-26-000004SEC ↗4Sep 3, 2026Period Sep 1, 20260001802639-26-000004SEC ↗10-QAug 7, 2026Period Jun 30, 20260001294133-26-000034SEC ↗8-KAug 6, 2026Period Aug 6, 20260001294133-26-000032SEC ↗4Jul 9, 2026Period Jul 6, 20260001478471-26-000007SEC ↗4Jul 6, 2026Period Jul 1, 20260002079957-26-000006SEC ↗Transaction semantics distinguish purchases, sales, awards, exercises, withholding, and derivatives.
GrossPattern stores immutable raw artifacts, accession-scoped facts, parser and metric versions, dependency edges, quality state, and channel-specific publication rights. A restricted or unknown ancestor blocks the page and API automatically.
SEC source policy ↗Raw value 7.03% · OPTIONAL
Level · gp.fundamentals.sbc_revenue_ratio
Raw value 2.12% · OPTIONAL
Inventory / revenue changed +357 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating margin changed +164 basis points from the comparable as-filed period.
Cash & equivalents changed -15.8% from the comparable as-filed period.
Operating income changed +16.9% from the comparable as-filed period.
Revenue changed +5.5% from the comparable as-filed period.
Gross margin changed -41 basis points from the comparable as-filed period.
Method note “Materiality” here is an analytical magnitude band, not a legal conclusion. Full filing-text semantic changes remain unpublished while excerpt rights and review thresholds are unresolved.
Latest supported period in this snapshot: 2026-06-30. Duration facts use direct quarterly or annual SEC contexts; GrossPattern does not manufacture missing Q4 values.
0001294133-26-000025